These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37596198)

  • 1. Structure-guided design of a broadly cross-reactive multivalent group a streptococcal vaccine.
    Dale JB; Aranha MP; Penfound TA; Salehi S; Smith JC
    Vaccine; 2023 Sep; 41(40):5841-5847. PubMed ID: 37596198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based group A streptococcal vaccine design: Helical wheel homology predicts antibody cross-reactivity among streptococcal M protein-derived peptides.
    Aranha MP; Penfound TA; Spencer JA; Agarwal R; Baudry J; Dale JB; Smith JC
    J Biol Chem; 2020 Mar; 295(12):3826-3836. PubMed ID: 32029479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactive immunogenicity of group A streptococcal vaccines designed using a recurrent neural network to identify conserved M protein linear epitopes.
    Spencer JA; Penfound T; Salehi S; Aranha MP; Wade LE; Agarwal R; Smith JC; Dale JB; Baudry J
    Vaccine; 2021 Mar; 39(12):1773-1779. PubMed ID: 33642159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study.
    Pastural É; McNeil SA; MacKinnon-Cameron D; Ye L; Langley JM; Stewart R; Martin LH; Hurley GJ; Salehi S; Penfound TA; Halperin S; Dale JB
    Vaccine; 2020 Feb; 38(6):1384-1392. PubMed ID: 31843270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of broadly protective group a streptococcal M protein-based vaccines.
    Dale JB; Smeesters PR; Courtney HS; Penfound TA; Hohn CM; Smith JC; Baudry JY
    Vaccine; 2017 Jan; 35(1):19-26. PubMed ID: 27890396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of Broadly Cross-Reactive M Protein-Based Group A Streptococcal Vaccines.
    Aranha MP; Penfound TA; Salehi S; Botteaux A; Smeesters P; Dale JB; Smith JC
    J Immunol; 2021 Aug; 207(4):1138-1149. PubMed ID: 34341168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci.
    Dale JB; Penfound TA; Chiang EY; Walton WJ
    Vaccine; 2011 Oct; 29(46):8175-8. PubMed ID: 21920403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine.
    Finn MB; Penfound TA; Salehi S; Ogega CO; Dold C; Plante O; Dale JB
    Vaccine; 2024 Sep; 42(22):126205. PubMed ID: 39141987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal
    Salie T; Engel K; Moloi A; Muhamed B; Dale JB; Engel ME
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of a 26-valent group A streptococcal vaccine.
    Hu MC; Walls MA; Stroop SD; Reddish MA; Beall B; Dale JB
    Infect Immun; 2002 Apr; 70(4):2171-7. PubMed ID: 11895984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity.
    Frost HR; Laho D; Sanderson-Smith ML; Licciardi P; Donath S; Curtis N; Kado J; Dale JB; Steer AC; Smeesters PR
    Clin Infect Dis; 2017 Oct; 65(9):1523-1531. PubMed ID: 29020160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential coverage of a multivalent M protein-based group A streptococcal vaccine.
    Dale JB; Penfound TA; Tamboura B; Sow SO; Nataro JP; Tapia M; Kotloff KL
    Vaccine; 2013 Mar; 31(12):1576-81. PubMed ID: 23375817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Immune Responses to Group A Streptococcal Antigens following Pharyngeal Acquisitions among Children in Cape Town, South Africa.
    Salie MT; Muhamed B; Engel K; Rampersadh K; Daniels R; Mhlanti L; Penfound TA; Sable CA; Zühlke LJ; Dale JB; Engel ME
    mSphere; 2023 Jun; 8(3):e0011323. PubMed ID: 37154726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial.
    Kotloff KL; Corretti M; Palmer K; Campbell JD; Reddish MA; Hu MC; Wasserman SS; Dale JB
    JAMA; 2004 Aug; 292(6):709-15. PubMed ID: 15304468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunity induced by an intranasal multivalent vaccine comprising 10 Lactococcus lactis strains expressing highly prevalent M-protein antigens derived from Group A Streptococcus.
    Wozniak A; Scioscia N; García PC; Dale JB; Paillavil BA; Legarraga P; Salazar-Echegarai FJ; Bueno SM; Kalergis AM
    Microbiol Immunol; 2018 Jun; 62(6):395-404. PubMed ID: 29704396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease.
    Giffard PM; Tong SYC; Holt DC; Ralph AP; Currie BJ
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007511. PubMed ID: 31269021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments.
    Dale JB
    Vaccine; 1999 Jan; 17(2):193-200. PubMed ID: 9987154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
    Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
    BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of synthetic, M type-specific peptides as antigens in a multivalent group A streptococcal vaccine.
    Bruner M; James A; Beall B; Carlone GM; Ades E; Johnson S; Guarner J; Sampson J
    Vaccine; 2003 Jun; 21(21-22):2698-703. PubMed ID: 12798606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population and Whole Genome Sequence Based Characterization of Invasive Group A Streptococci Recovered in the United States during 2015.
    Chochua S; Metcalf BJ; Li Z; Rivers J; Mathis S; Jackson D; Gertz RE; Srinivasan V; Lynfield R; Van Beneden C; McGee L; Beall B
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.